Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Melero

Showing results (111-120 of 351) with videos related to

Pageof 36
Sort By:
Immunology and Cell Biology|February 1, 2017
Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cellsMaria Carmen Ochoa, Luna Minute, Inmaculada Rodriguez, et al.
The Journal of Investigative Dermatology|March 24, 2007
Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesionsPedro Redondo, Julio del Olmo, Ascensión López-Diaz de Cerio, et al.
Journal of Virology|September 27, 2003
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responsesPablo Sarobe, Juan José Lasarte, Aintzane Zabaleta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2016
Intratumoral Delivery of Immunotherapy-Act Locally, Think GloballyM Angela Aznar, Nicola Tinari, Antonio J Rullán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arenaIgnacio Melero, Ainhoa Arina, Oihana Murillo, et al.
Expert Opinion on Drug Discovery|September 9, 2021
Advances in mRNA-based drug discovery in cancer immunotherapyClaudia Augusta Di Trani, Myriam Fernandez-Sendin, Assunta Cirella, et al.
International Review of Cell and Molecular Biology|July 1, 2022
Overcoming the limitations of cytokines to improve cancer therapyClaudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2011
International symposium on CTL and immunostimulation, Pamplona (Spain), October 26th and 27th 2010Maria C Ochoa, Sandra Hervas-Stubbs, Asis Palazon, et al.
Journal for Immunotherapy of Cancer|February 28, 2020
Repurposing infectious disease vaccines for intratumoral immunotherapyIgnacio Melero, Maria Gato, Tala Shekarian, et al.
Nature Cancer|August 23, 2022
Cancer vaccines: the next immunotherapy frontierMatthew J Lin, Judit Svensson-Arvelund, Gabrielle S Lubitz, et al.
Pageof 36

Showing results (111-120 of 351) with videos related to

Sort By:
Pageof 36
Immunology and Cell Biology|February 1, 2017
Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cellsMaria Carmen Ochoa, Luna Minute, Inmaculada Rodriguez, et al.
The Journal of Investigative Dermatology|March 24, 2007
Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesionsPedro Redondo, Julio del Olmo, Ascensión López-Diaz de Cerio, et al.
Journal of Virology|September 27, 2003
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responsesPablo Sarobe, Juan José Lasarte, Aintzane Zabaleta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2016
Intratumoral Delivery of Immunotherapy-Act Locally, Think GloballyM Angela Aznar, Nicola Tinari, Antonio J Rullán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arenaIgnacio Melero, Ainhoa Arina, Oihana Murillo, et al.
Expert Opinion on Drug Discovery|September 9, 2021
Advances in mRNA-based drug discovery in cancer immunotherapyClaudia Augusta Di Trani, Myriam Fernandez-Sendin, Assunta Cirella, et al.
International Review of Cell and Molecular Biology|July 1, 2022
Overcoming the limitations of cytokines to improve cancer therapyClaudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, et al.
Cancer Immunology, Immunotherapy : CII|March 8, 2011
International symposium on CTL and immunostimulation, Pamplona (Spain), October 26th and 27th 2010Maria C Ochoa, Sandra Hervas-Stubbs, Asis Palazon, et al.
Journal for Immunotherapy of Cancer|February 28, 2020
Repurposing infectious disease vaccines for intratumoral immunotherapyIgnacio Melero, Maria Gato, Tala Shekarian, et al.
Nature Cancer|August 23, 2022
Cancer vaccines: the next immunotherapy frontierMatthew J Lin, Judit Svensson-Arvelund, Gabrielle S Lubitz, et al.
Pageof 36